William Demant (WILYY) Stock Rating Lowered by Zacks Investment Research

William Demant (OTCMKTS:WILYY) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Wednesday.

According to Zacks, “William Demant Holding A/S develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Company focuses on three business areas: Hearing Devices, Diagnostic Instruments and Personal Communication. William Demant Holding A/S is headquartered in Smorum, Denmark. “

Shares of WILYY opened at $18.63 on Wednesday. William Demant has a fifty-two week low of $12.27 and a fifty-two week high of $19.60. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.70 and a current ratio of 0.94.

William Demant Company Profile

William Demant Holding A/S, a hearing healthcare company, develops, manufactures, and sells products and equipment designed to aid the people with hearing loss connect and communication primarily in Denmark, rest of Europe, North America, Oceania, Asia, and other countries. Its products include hearing devices and implants; diagnostic instruments; and personal communication systems, such as headsets and solutions for the professional call center and office market, as well as consumer headsets for the gaming and mobile segments.

Get a free copy of the Zacks research report on William Demant (WILYY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for William Demant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for William Demant and related companies with MarketBeat.com's FREE daily email newsletter.



Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit